Autolus Therapeutics (AUTL) EBT Margin Growth (1y) (2018 - 2025)

Autolus Therapeutics (AUTL) EBT Margin Growth (1y) (2018 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (1y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1,526.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1,558.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -683.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 452.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Autolus Therapeutics 404.53 Mn 103.82 Mn -1.04 Mn 8.98 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 8.98 Mn
Mar 31, 2025 -23,459.00
Mar 31, 2024 256,067.00
Sep 30, 2023 -949,254.00
Mar 31, 2023 1.93 Mn
Sep 30, 2022 1.49 Mn
Mar 31, 2022 -784,774.00
Sep 30, 2021 -636,968.00
Jun 30, 2021 1.07 Mn
Mar 31, 2021 -456,277.00
Jun 30, 2020 -1.06 Mn
Mar 31, 2020 -837,361.00
Jun 30, 2019 51,929.00
Dec 31, 2018 -308,204.00